Russell Pachynski, MD

Articles by Russell Pachynski, MD

Russell Pachynski, MD, associate professor of medicine, Division of Medical Oncology, Washington University School of Medicine in St Louis, medical oncologist, Siteman Cancer Center

Dr Pachynski on the Ongoing Investigation of ARX517 in Advanced Solid Tumors

ByRussell Pachynski, MD

October 17th 2023

Russell Pachynski, MD, discusses the ongoing investigation of ARX517 in patients with advanced solid tumors in the phase 1/2 APEX-01 trial.

Latest Updated Articles

Trending on OncLive

Tam-Peli Reduces Risk of Death by 54% vs Topotecan in Relapsed SCLC

Ris-Rez Extends Median OS to 18.5 Months vs Topotecan in Relapsed SCLC

Early Discontinuation of Adjuvant Osimertinib Doubles Recurrence Risk in EGFR-Mutated NSCLC

Dr Felip on Sequencing Next-Generation ROS1 TKIs After Progression in NSCLC

Dr Liu on Building on the ADRIATIC Regimen in Limited-Stage Small Cell Lung Cancer